PR
PROCEPT BioRobotics
PRCT · NASDAQ
$22.76 +7.41% (+$1.57)
1M +4.84%
Market Cap $1.30B
P/E Ratio -
Div. Yield -
ROE 30.62%
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 3.84x
P/B 3.81x
P/E N/A
Growth
100 /100
Growing Rev. growth 60.14%
Book val. growth 22.90%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 63.74%
Net margin 32.54%
Op. margin 33.86%
Quality
9 /100
Poor ROIC 27.42%
ROE 30.62%
ROA 22.90%
Debt
69 /100
Low Debt/Equity 0.23x
Current ratio 6.55x
Int. coverage -30.52x
Stability
68 /100
Stable Beta 0.90x
Rev. volatility 22.39%
EPS volatility 18.12%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PRCT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Larry L. Wood
Employees
888
Headquarters
San Jose
Upcoming events
03 NOV
Earnings
Upcoming earnings report